patientcareonline.com
FDA Approves Lilly's Mirikizumab-mrkz for Crohn's Disease - Patient Care Online
Cure8 flagged this item because the article title and available source metadata connect it to Crohn's disease, Inflammatory bowel disease, Mirikizumab, and IL-23 inhibitor. We do not yet have enough reliable article text to summarize the details.
This may be most useful for Clinicians and Adult patients following Crohn's disease, Inflammatory bowel disease, Mirikizumab, IL-23 inhibitor, and Medications.
What To Know
Cure8 does not have enough reliable source text to summarize this article yet. Based on the article title and source metadata, this appears to be a fda approval related to Crohn's disease, Inflammatory bowel disease, Mirikizumab, and IL-23 inhibitor. Use the original source link for the full details.
The original article from patientcareonline.com has the full details, including any study limitations or source context.
